vTv Therapeutics (VTVT) Operating Leases (2019 - 2025)
vTv Therapeutics (VTVT) posted Operating Leases of $125000.0 for Q1 2025, up 290.62% sequentially from $32000.0 in Q3 2024, and down 58.05% YoY from $298000.0 in Q1 2024.
vTv Therapeutics (VTVT) Operating Leases (2019 - 2025) Analysis & Trends
vTv Therapeutics has reported Operating Leases for 7 years, with the latest figure at $125000.0 in Q1 2025.
- Quarterly Operating Leases fell 58.05% year-over-year to $125000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $125000.0 (down 58.05% YoY) and the FY2023 annual result came in at $169000.0, down 50.0% from the prior year.
- Operating Leases advanced to $125000.0 in Q1 2025 per VTVT's latest filing, from $32000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $633000.0 in Q1 2021 and troughed at $32000.0 in Q3 2024.
- A 5-year average of $348812.5 and a median of $335500.0 in 2022 frame the typical range for Operating Leases.
- The widest YoY moves for Operating Leases: up 0.34% in 2024, down 84.98% in 2024.
- Over 5 years, Operating Leases stood at $492000.0 in 2021, then slumped by 31.3% to $338000.0 in 2022, then slumped by 50.0% to $169000.0 in 2023, then plunged by 81.07% to $32000.0 in 2024, then jumped by 290.62% to $125000.0 in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $125000.0, $32000.0, and $79000.0 for Q1 2025, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | vTv Therapeutics | 373.77 Mn | 373.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 125,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 298,000.00 |
| Dec 31, 2023 | 169,000.00 |
| Sep 30, 2023 | 213,000.00 |
| Jun 30, 2023 | 417,000.00 |
| Mar 31, 2023 | 297,000.00 |
| Dec 31, 2022 | 338,000.00 |
| Sep 30, 2022 | 333,000.00 |
| Jun 30, 2022 | 587,000.00 |
| Mar 31, 2022 | 441,000.00 |
| Dec 31, 2021 | 492,000.00 |
| Sep 30, 2021 | 540,000.00 |
| Jun 30, 2021 | 587,000.00 |
| Mar 31, 2021 | 633,000.00 |
| Dec 31, 2020 | 676,000.00 |
| Sep 30, 2020 | 717,000.00 |
| Jun 30, 2020 | 756,000.00 |
| Mar 31, 2020 | 795,000.00 |